Relay Therapeutics, Inc. ( RLAY) - Key Metrics
RLAY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.41 | -$0.27 | -$0.27 |
| 2026Q1 | $0.02 | -$0.41 | -$0.28 | -$0.28 |
| 2025Q4 | $0.04 | -$0.32 | -$0.26 | -$0.26 |
| 2025Q3 | $0 | -$0.43 | -$0.36 | -$0.36 |
| 2025Q2 | $0 | -$0.41 | -$0.32 | -$0.32 |
RLAY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.41 |
| 2026Q1 | 0% | -6.07 |
| 2025Q4 | 0% | -6.61 |
| 2025Q3 | 0% | -3.03 |
| 2025Q2 | 0% | -2.11 |
RLAY
Price: $19.86
52 week price:
Earnings Per Share: -1.57 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.4 million
Market Capitalization: 4.4 billion